These effects, along with a earlier report showing that a small-molecule ACKR3 agonist CCX771 reveals anxiolytic-like actions in mice,2 assistance the strategy of targeting ACKR3 as a novel way to modulate the opioid system, which could open new therapeutic avenues for opioid-connected Ailments.